BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8592654)

  • 1. Stabilization of the hydrophilic sphere of iobitridol, an iodinated contrast agent, as revealed by experimental and computational investigations.
    Meyer D; Fouchet MH; Petta M; Carrupt PA; Gaillard P; Testa B
    Pharm Res; 1995 Nov; 12(11):1583-91. PubMed ID: 8592654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of the hydrophilic sphere of iobitridol, a new nonionic iodinated contrast agent.
    Meyer D; Petta M; Fouchet MH; Vadel M; Schaefer M; Dugast-Zrihen M; Guillemot M
    Acta Radiol Suppl; 1996; 400():8-16. PubMed ID: 8619359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the complex between the contrast agent Iobitridol (Xenetix) and Elastase (PPE): a model for hydrophobic site protection in drug-protein interactions.
    Prangé T; Neuman A; Corot C; Meyer D
    Pharm Res; 1997 Dec; 14(12):1713-7. PubMed ID: 9453058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of the hydrophilic sphere of iobitridol.
    Carrupt PA; Testa B
    Br J Radiol; 2003 Feb; 76(902):147; author reply 147-8. PubMed ID: 12642287
    [No Abstract]   [Full Text] [Related]  

  • 5. Stabilization of the hydrophilic sphere of non-ionic monomers: are all protected in a similar way?
    Violon D
    Br J Radiol; 2001 Dec; 74(888):1097-102. PubMed ID: 11777766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iobitridol: a review of its use as a contrast medium in diagnostic imaging.
    McCormack PL
    Clin Drug Investig; 2013 Feb; 33(2):155-66. PubMed ID: 23341290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the lateral/facial protection model to a new molecule, iobitridol.
    Violon D
    Invest Radiol; 1996 Oct; 31(10):668-70. PubMed ID: 8889656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelography iodinated contrast media. I. Unraveling the atropisomerism properties in solution.
    Fontanive L; D'Amelio N; Cesàro A; Gamini A; Tavagnacco L; Paolantoni M; Brady JW; Maiocchi A; Uggeri F
    Mol Pharm; 2015 Jun; 12(6):1939-50. PubMed ID: 25945970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of iobitridol in plasma, urine and bile.
    Bourrinet P; Feldman H; Dencausse A; Chambon C; Bonnemain B
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):369-72. PubMed ID: 8548031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization.
    Fu Y; Nitecki DE; Maltby D; Simon GH; Berejnoi K; Raatschen HJ; Yeh BM; Shames DM; Brasch RC
    Bioconjug Chem; 2006; 17(4):1043-56. PubMed ID: 16848414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of iobitridol in an injectable preparation by 1H NMR spectroscopy.
    Borioni A; Gostoli G; Bossù E; Sestili I
    J Pharm Biomed Anal; 2014 Jun; 94():19-22. PubMed ID: 24531005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isomerism in iohexol and ioxilan. Analysis and implications.
    Foster SJ; Sovak M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S106-9. PubMed ID: 3198329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental passage and milk excretion of iobitridol.
    Bourrinet P; Dencausse A; Havard P; Violas X; Bonnemain B
    Invest Radiol; 1995 Mar; 30(3):156-8. PubMed ID: 7797413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of iobitridol.
    Dencausse A; Violas X; Feldman H; Havard P; Chambon C
    Acta Radiol Suppl; 1996; 400():25-34. PubMed ID: 8619349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of biodistribution and changes in density following administration of iobitridol in rabbits. A comparative study vs iohexol.
    Rouleau P; Alison D; Bertrand P; Benderbous S; Havard P; Chambon C
    Acta Radiol Suppl; 1996; 400():49-55. PubMed ID: 8619352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Iodinated Radiographic Contrast Media on Multidrug-resistant K562/Dox Cells: Mitochondria Impairment and P-glycoprotein Inhibition.
    Supawat B; Udomtanakunchai C; Kothan S; Tungjai M
    Cell Biochem Biophys; 2019 Jun; 77(2):157-163. PubMed ID: 30924055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicologic profile of iobitridol, a new nonionic low-osmolality contrast medium.
    Donandieu AM; Idee JM; Doucet D; Legros A; Penati S; Nain-Dit-Ducret M; Marmion F; Bonnemain B
    Acta Radiol Suppl; 1996; 400():17-24. PubMed ID: 8619348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the dialysability of iobitridol and iohexol in the rat with impaired renal function.
    Dencausse A; Chambon C; Violas X; Bonnemain B
    Acta Radiol; 1995 Sep; 36(5):545-8. PubMed ID: 7640101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Triperidin (Norakin): separation, stability and structure of stereoisomers].
    Pfeifer S; Haussner M; Gründemann E; Lücke L
    Pharmazie; 1988 Feb; 43(2):102-5. PubMed ID: 3393574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.